Name:
ZepzelcaTM (lurbinectedin: development of innovative drugs through marine organisms)
Developed by:
PHARMAMAR, SPAINSpain
Funding sources:
National
General idea:
Zepzelca (lurbinectedin), also known as PM1183, is an analog of the marine compound ET-736 isolated from the sea squirt Ecteinacidia turbinata in which a hydrogen atom has been replaced by a methoxy group.
TRL:
9. Actual system proven in operational environment
IPR involved:
Yes
Sources:
https://pharmamar.com/science-and-innovation/oncology-pipeline/?lang=en